Home › Funds › Meadowbrook Wealth Management, LLC › ABT

Meadowbrook Wealth Management, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Meadowbrook Wealth Management, LLC reported holding 9,000 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$889K, representing 0.93% of its reported portfolio and ranking #26 among its reported holdings. Meadowbrook Wealth Management, LLC has disclosed ABT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)9.00K sh
Reported value held$889.47K
Portfolio Weight0.93%
First reportedQ3 2025
Last changeAdd
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Meadowbrook Wealth Management, LLC's ABT position evolved

Meadowbrook Wealth Management, LLC first disclosed a stake in ABT in Q3 2025 at 9,270 shares (US$1.2M). Across 5 filings, Meadowbrook Wealth Management, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 9,000 shares valued at US$889K — an increase of 100 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 9.27K $1.24M New
Q4 2025 9.27K $1.16M Hold
Q1 2026 9.07K $931.22K Reduce
Q2 2026 8.90K $820.40K Reduce
Q3 2026 9.00K $889.47K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Meadowbrook Wealth Management, LLC held ABT?

Meadowbrook Wealth Management, LLC has disclosed ABT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Meadowbrook Wealth Management, LLC's current position in ABT?

As of Q3 2026, Meadowbrook Wealth Management, LLC holds 9.00K shares of ABT (ABBOTT LABORATORIES), valued at $889.47K, representing 0.93% of its reported portfolio and ranking #26.

Has Meadowbrook Wealth Management, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Meadowbrook Wealth Management, LLC increased its position in ABT.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.